Mike Nally, CEO of Generate Biomedicines and CEO-Partner at Flagship Pioneering, explains how the company is leveraging computation to generate novel protein therapeutics and accelerate the pace of drug discovery and development. More from Flagship @ JPM2023 here.
Related Companies
- Generate:Biomedicines Founded: 2018
